tiprankstipranks
Advertisement

DBEF - ETF AI Analysis

Compare

Top Page

DBEF

Xtrackers MSCI EAFE Hedged Equity ETF (DBEF)

Rating:65Neutral
Price Target:
DBEF’s rating reflects a solid, diversified mix of high-quality international companies, especially leaders like ASML, AstraZeneca, HSBC, and Novartis, which are backed by strong financial performance and generally positive outlooks. These strengths are partly offset by holdings such as Commonwealth Bank of Australia and Mitsubishi UFJ Financial Group, where leverage, cash flow issues, or bearish technical signals introduce some risk. The main risk factor is the fund’s exposure to several large financial institutions, which can add sensitivity to banking-sector and economic conditions.
Positive Factors
Strong Recent Performance
The ETF has shown solid gains over the year so far and in recent months, indicating positive momentum in its underlying markets.
Leading Top Holdings
Several of the largest positions, including ASML, Shell, and BHP, have delivered strong year-to-date performance, helping drive the fund’s returns.
Broad International Diversification
The fund spreads its investments across many developed countries and sectors, which can help reduce the impact of weakness in any single market or industry.
Negative Factors
Moderate Expense Ratio
The fund’s fee is not especially low for a large index-based ETF, which slightly reduces the net return investors keep over time.
Underperforming Defensive Holdings
Some major defensive stocks like Nestlé and Roche have been weak this year, which has held back part of the portfolio.
Heavy Exposure to Financials and General Industries
A sizable allocation to financial and broad industrial companies means the fund can be sensitive to global economic and interest-rate cycles.

DBEF vs. SPDR S&P 500 ETF (SPY)

DBEF Summary

DBEF is an ETF that follows the MSCI EAFE index, which covers large and mid-sized companies in developed markets outside the U.S. and Canada, such as Japan, the UK, and Europe. It owns many well-known international names like Nestlé and Shell, and it uses a strategy to reduce the impact of foreign currency swings against the U.S. dollar. Investors might consider DBEF to diversify beyond the U.S. while keeping currency movements more stable. A key risk is that it still invests in stocks, so its value can go up or down with global markets.
How much will it cost me?The Xtrackers MSCI EAFE Hedged Equity ETF (DBEF) has an expense ratio of 0.35%, which means you’ll pay $3.50 per year for every $1,000 invested. This is slightly higher than average for passively managed ETFs because it includes a currency hedging strategy to reduce the impact of exchange rate fluctuations. This added feature makes it a bit more expensive but can be valuable for international investors seeking stability.
What would affect this ETF?The DBEF ETF could benefit from economic growth in developed markets outside North America, particularly in Europe and Asia, as well as strong performance in sectors like financials and industrials, which make up a significant portion of its holdings. However, it may face challenges from global economic slowdowns, regulatory changes in key regions, or sector-specific risks such as fluctuating energy prices impacting companies like Shell. Additionally, while its currency hedging strategy helps mitigate exchange rate risks, unexpected shifts in currency policies or geopolitical tensions could still impact overall returns.

DBEF Top 10 Holdings

DBEF’s story is all about big developed-market leaders outside the U.S., with a noticeable tilt toward European health care, financials, and industrials. ASML has been a key engine for returns, rising steadily and giving the fund a tech-powered boost, while BHP’s strong run in resources adds extra fuel. HSBC and Commonwealth Bank are also climbing, helping the financial side pull its weight. On the flip side, Roche has been lagging and Nestlé looks a bit sleepy, softening the impact of the fund’s otherwise solid, globally diversified lineup across Europe and Asia-Pacific.
Name
Company Name
Weight %
Market Value
Market Cap
Yearly Gain
Overall Rating
ASML Holding NV2.70%$232.93M€498.49B113.07%
76
Outperform
HSBC Holdings1.43%$122.84M£230.84B59.32%
80
Outperform
Roche Holding AG1.32%$113.47M$330.18B27.90%
73
Outperform
AstraZeneca1.30%$111.88M$286.22B29.15%
80
Outperform
Novartis AG1.28%$110.23MCHF211.11B25.94%
80
Outperform
Nestlé SA1.18%$101.74MCHF198.82B-4.90%
71
Outperform
Shell (UK)1.13%$97.10M£179.32B32.21%
73
Outperform
Siemens1.09%$93.85M€204.52B27.59%
74
Outperform
Commonwealth Bank of Australia0.98%$84.42MAU$297.55B7.24%
64
Neutral
BHP Group Ltd0.94%$81.18MAU$286.50B75.00%
68
Neutral

DBEF Technical Analysis

Technical Analysis Sentiment
Positive
Last Price
Price Trends
50DMA
50.48
Positive
100DMA
50.12
Positive
200DMA
47.82
Positive
Market Momentum
MACD
0.28
Negative
RSI
54.45
Neutral
STOCH
82.02
Negative
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For DBEF, the sentiment is Positive. The current price of undefined is equal to the 20-day moving average (MA) of 51.48, equal to the 50-day MA of 50.48, and equal to the 200-day MA of 47.82, indicating a bullish trend. The MACD of 0.28 indicates Negative momentum. The RSI at 54.45 is Neutral, neither overbought nor oversold. The STOCH value of 82.02 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for DBEF.

DBEF Peer Comparison

Comparison Results
Name
Price
Price Target
AUM
Expense Ratio
Overall Rating
$8.61B0.35%
65
Neutral
$9.10B0.28%
67
Neutral
$6.35B0.07%
66
Neutral
$5.36B0.20%
61
Neutral
$2.18B0.58%
69
Neutral
$1.57B0.20%
60
Neutral
Performance Comparison
Ticker
Company Name
Price
Change
% Change
DBEF
Xtrackers MSCI EAFE Hedged Equity ETF
51.64
10.20
24.61%
FENI
Fidelity Enhanced International ETF
BBIN
JPMorgan BetaBuilders International Equity ETF
EFAV
iShares MSCI EAFE Min Vol Factor ETF
IHDG
WisdomTree International Hedged Quality Dividend Growth Fund
HFXI
IQ 50 Percent Hedged FTSE International ETF
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
DisclaimerThis AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents
Advertisement